Myriad Genetics discloses Nov 2 network breach; testing and order systems temporarily suspended

MYRIAD GENETICS INC

Detected unauthorized access within its IT network environment on November 2, 2026; initiated incident response and engaged external experts.
Temporarily suspended testing operations and order management systems and reset certain system credentials to contain the activity.
Investigation ongoing into full scope, including whether any patient records were accessed on systems containing patient information.
Most systems have returned to normal operations; company does not believe the incident will have a material adverse effect on its business.

Featured in Daily 8-K Digest

Selected #1 for 2026-11-05. Read digest

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.